Korean J healthc assoc Infect Control Prev.  2019 Dec;24(2):103-107. 10.14192/kjicp.2019.24.2.103.

Two Cases of Chickenpox Developed from an Immunocompromised Patient with Localized Herpes Zoster

Affiliations
  • 1Department of Infectious Disease, Ajou University School of Medicine, Suwon, Korea.
  • 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. shhan@yuhs.ac
  • 3Infection Control Department, Severance Hospital, Seoul, Korea.
  • 4Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Varicella zoster virus causes chickenpox, which is highly contagious, at primary infection and herpes zoster at reactivation. The varicella zoster virus may be more contagious and cause serious outbreaks in immunocompromised patients. There are some reports of outbreaks of chickenpox in patients with herpes zoster. Here, we describe a case of localized herpes zoster occurring in an immunocompromised patient during hospitalization in a specialized ward for immunocompromised patients. This episode resulted in two newly developed, hospital-acquired cases of chickenpox. If we had isolated the index patient who had localized herpes zoster immediately, the two cases of chickenpox could have been prevented. Therefore, patients with localized herpes zoster should be isolated in wards with immunocompromised patients.

Keyword

Chickenpox; Herpes zoster; Immunocompromised host

MeSH Terms

Chickenpox*
Disease Outbreaks
Herpes Zoster*
Herpesvirus 3, Human
Hospitalization
Humans
Immunocompromised Host*

Figure

  • Fig. 1 Histopathological examination of skin biopsy, taken from Case 2 patient, shows acantholysis and intranuclear inclusions at the infected cells (H&E=400×).

  • Fig. 2 Room arrangement of involved ward. The shade of each room shows nurses' duty. The dates indicate occurrences of hospital-acquired varicella after the development of skin lesion in index (Case 1) patient.


Reference

1. Cohen JI, Straus SE, Arvin AM. Varicella-Zoster Virus replication, pthogenesis and management. In : Fields BN, Knipe DM, Howley PM, editors. Fields' virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins;2007. p. 2773–2818.
2. Juel-Jensen BE. Outbreak of chickenpox from a patient with immunosuppressed herpes zoster in hospital. Br Med J (Clin Res Ed). 1983; 286:60.
Article
3. Saidel-Odes L, Borer A, Riesenberg K, Frenkel A, Sherlis R, Bouhnick L, et al. An outbreak of varicella in staff nurses exposed to a patient with localized herpes zoster. Scand J Infect Dis. 2010; 42:620–622.
Article
4. LaRussa P. Clinical manifestations of varicella. In : Arvin AM, Gershon AA, editors. Varicella-zoster virus : virology and clinical management. Cambridge: Cambridge University Press;2000. p. 206–219.
5. Krah DL. Assays for antibodies to varicella-zoster virus. Infect Dis Clin North Am. 1996; 10:507–527.
Article
6. Marin M, Güris D, Chaves SS, Schmid S, Seward JF. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-4):1–40.
7. Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics. 1986; 78(4 Pt 2):748–756.
8. Huang YC, Lin TY, Chiu CH. Acyclovir prophylaxis of varicella after household exposure. Pediatr Infect Dis J. 1995; 14:152–154.
Full Text Links
  • KJHAICP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr